Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 106Gynecologic 6Thoracic 2Gastrointestinal 2Endocrine 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Classical hematology 1CNS 1

Conditions

Glioma 8Glioblastoma 6Medulloblastoma 4Diffuse Intrinsic Pontine Glioma 4Brain Neoplasms 4Neuroblastoma 3Astrocytoma 3Rhabdoid Tumor 2Recurrence 2Neoplasms 2Meningioma 2Rhabdomyosarcoma 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Neuroepithelial 1Neoplasms, Germ Cell and Embryonal 1Microphthalmia, Isolated, with Coloboma 5 1Lymphoma, Follicular 1Familial ependymoma 1Ependymoma 1Choroid Plexus Carcinoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

Trastuzumab 20Radiosurgery 15Magnetic Resonance Spectroscopy 15Capecitabine 14Lapatinib 12Radiotherapy 11Specimen Handling 10Cyclophosphamide 9trastuzumab deruxtecan 8Temozolomide 8Docetaxel 8Paclitaxel 7Gemcitabine 6Cisplatin 6sacituzumab govitecan 5Vinorelbine 5Therapeutics 5Spinal Puncture 5Flow Cytometry 5tucatinib 4pembrolizumab 4paclitaxel-Angiopep-2 conjugate 4eribulin 4Methotrexate 4Irinotecan 4Fluorodeoxyglucose F18 4Dexamethasone 4Bevacizumab 4temsirolimus 3pyrotinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × ribociclib × CNS × Clear all
NCT04585724 2021-10-18

Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases

Emory University

Phase 1 Withdrawn
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡